Principal Financial Group, Inc. (NASDAQ: PFG) — A De-Risked Capital-Return Machine Re-Rated to a Record Multiple While Its Assets Quietly Walk Out the Door

Independent fundamental research. Report date: 2026-07-11. Price reference: $112.23 (close 2026-07-10); intraday all-time high $112.88 on 2026-07-07.

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only. It is not investment advice and not a recommendation to buy or sell any security. The analytical body of this article below takes no position, carries no price target, and remains recommendation-free.

Call: HOLD / trim-into-strength / AVOID-here. Not-a-short. Medium conviction. Fair-value zone ~$85–100 — roughly 10–12x through-cycle non-GAAP operating EPS of ~$8.30–9.00, or ~1.15–1.35x book value ex-AOCI of ~$74/share. I’d become a genuine accumulator only in the ~$78–88 band (~1.05–1.20x book ex-AOCI, ~10x operating EPS, a starting dividend yield back above ~3.5%), and I’d actively trim enthusiasm here at ~$112 (~13.5x trailing / ~12.4x forward operating, an all-time-high price at the 96th percentile of its own ten-year valuation range).

The thing to understand about Principal is that it is a genuinely better, safer business than it was five years ago — and the market has now fully paid for that improvement, and then some. The 2021 Elliott-driven strategic review was the right surgery: Principal reinsured away its capital-hungry US retail fixed-annuity and universal-life-with-secondary-guarantee blocks (to a Talcott/Sixth Street vehicle), freed a mountain of statutory capital, and re-pointed the company at three capital-lighter engines — workplace retirement (RIS), asset management (PAM), and group benefits (B&P). Operating ROE climbed from ~12.8% (2023) to ~15.2% (2025), the balance sheet is legitimately strong (holdco liquidity ~$2.4B against an ~$800M target, only 4.9% below-investment-grade credit, RBC ~400%), and management has returned 108–220% of GAAP net income to shareholders every year, shrinking the share count ~20% since 2020. That is a real, well-run, de-risked capital-return machine.

But three facts sit uncomfortably against a record price. First, the growth is engineered, not organic: operating dollar earnings have compounded at ~8%, and the headline EPS growth on top of that is buybacks — while book value ex-AOCI has gone nowhere (~$72→$74) because the company pays out more than it earns. Second, the asset-management engine is in perpetual net outflow — PAM has bled net cash flow every single year (−$8.8B, −$5.9B, −$10.6B in 2023–25); AUM only rose because markets and FX bailed it out. The “integrated flywheel” story is two-thirds hollow: only ~30% of the assets Principal recordkeeps are actually managed by its own PAM. Third, the entire ~44% twelve-month rally is multiple, not earnings — BofA correctly notes the forward operating P/E re-rated from ~8x to ~11x (and it’s ~12–13x now). Insiders have not bought a single share on the open market through the run; the buybacks are mechanical (~$82 average, valuation-indifferent). This is the classic setup where a good business becomes a mediocre investment because the price has borrowed the next several years of returns.

The framing is quality-at-a-full-price / a value-and-income re-rate that is now spent — and the tape agrees it is not a momentum or growth stock: PFG loads +0.50 on Dividend-Yield, +0.41 on Insurance, +0.34 on Credit-Risk and +0.30 on Value, with negative Growth (−0.22) and roughly neutral Momentum. What ran was a cheap, out-of-favor income financial mean-reverting to (and through) fair value on a financials-sector tailwind — not a franchise inflecting. Conviction: medium. Bull-flip: PAM net cash flow turns durably positive (the ~$9B commitment pipeline funding, private-markets/international flows offsetting the active-equity bleed) and operating EPS growth re-accelerates into the low-teens — that would justify a quality re-rate and I’d move to constructive. Bear-flip: a credit-cycle turn drives CRE/private-credit impairments through the general account (the +0.34 credit-risk loading, an −91% lifetime drawdown that remembers 2008), or the sell-side “decelerating-growth” call (BofA, PT $95) plays out as flows stay negative and the multiple round-trips back toward 9–10x.

Tag: “The buybacks bought the all-time high; the net flows are telling a different story.”

📈 Stock Price Action — Five-Year Event Map

Over five years PFG has gone from a de-risking special-situation to an all-time-high momentum-looking chart that the factor model insists is really a value/income re-rate. The arc in plain numbers: from a COVID low of ~$23 (2020) and a 2021 base in the high-$40s–low-$70s, the stock spent four full years range-bound between roughly $61 and $96 (2022–2025) as a classic cheap, capital-returning financial — then broke decisively to an all-time high in the first half of 2026, running from ~$79 (mid-2025) to an intraday record $112.88 on 2026-07-07. It now sits at $112.23, essentially at its 52-week and all-time high (range ~$75.53–$112.88), having returned ~+44% over the trailing twelve months — a move that is almost entirely multiple expansion, not earnings.

Price moves are FACT (split/dividend-adjusted AZI price series; calendar-year highs/lows cross-checked to ROIC). Attributed drivers are INTERPRETATION, cross-referenced to earnings dates, 8-K events, the 2021 Elliott review, the 2022 reinsurance transactions, the 2023 regional-bank macro, and the 2026-06-24 BofA downgrade. No price target or recommendation is implied — the opportunity judgment lives in Claude’s Take above.

Cycle narrative. (1) 2021 was a special-situation/value re-rate: activist Elliott took a stake and pushed a strategic review of a conglomerate that had traded below peers. (2) 2022 was the de-risking payoff — Principal reinsured its capital-intensive US retail fixed-annuity and ULSG blocks and exited those markets, while rising rates flattered spread income; the stock ended the year near $84 despite a mid-year swoon to ~$61. (3) The five-year low of ~$65 in 2023 was pure sector contagion: the SVB failure triggered a market-wide fear that life-insurer CRE and unrealized bond losses would impair capital; PFG’s GAAP earnings were simultaneously depressed by a large non-cash funds-withheld embedded-derivative mark (−$1.09B). (4) 2024 was a range-bound year — markets re-inflated AUM and buybacks compounded, but the stock went nowhere. (5) 2025 was a steady grind on the clean CEO succession, an operating-ROE march to 15%, and a benefits-underwriting bounce. (6) The defining recent event is the 1H-2026 breakout to an all-time high: a broad financials-sector re-rate plus two strong prints (Q4-25 and Q1-26 operating-EPS growth of ~13% at a 16% ROE) drove the multiple — not the earnings base — from ~8x forward operating to ~13x, carrying the stock straight through a 2026-06-24 BofA downgrade-to-Underperform ($95 PT) that flagged exactly this re-rating.

1. Executive Summary

Principal Financial Group is a ~$24.4B-market-cap, Des Moines–based diversified financial with three operating engines: Retirement & Income Solutions (RIS, ~45% of segment operating earnings) — one of the larger US workplace defined-contribution recordkeepers, plus pension risk transfer (PRT), annuities and Principal Bank/Trust; Principal Asset Management (PAM, ~35%) — Principal Global Investors (equities, fixed income, and a genuinely strong real-estate/alternatives franchise) plus Principal International pension JVs across Latin America and Asia; and Benefits & Protection (B&P, ~20%) — a top-tier small/mid-business group-benefits (dental, life, disability) and individual-life franchise. Total managed AUM was $781.0B and AUA $1,814.6B at year-end 2025.

The business is better than it was. The 2021 Elliott strategic review catalyzed a real de-risking: Principal reinsured and exited its capital-hungry US retail fixed-annuity and universal-life-with-secondary-guarantee blocks, freeing statutory capital and shifting the mix toward capital-lighter fee and premium income. Non-GAAP operating ROE rose from 12.8% (2023) to 15.2% (2025), inside management’s 14–16% target. The balance sheet is a genuine strength: ~$2.4B holdco liquidity (target ~$800M), only 4.9% below-investment-grade credit, problem commercial mortgages at 1.28%, and RBC ~400%. Capital return is aggressive and consistent — $1.59B in 2025 (≈85% of operating earnings), a 12-quarter dividend-raise streak, and a ~20% share-count reduction since 2020.

But the investment case is now priced for a quality it only partly possesses. Three tensions dominate: (1) the asset-management engine is in structural net outflow — PAM net cash flow was negative every year (−$8.8B / −$5.9B / −$10.6B in 2023–25); AUM grew only on market appreciation and FX. (2) Growth is engineered — operating dollar earnings compound at ~8%, headline EPS growth is buyback-assisted, and book value ex-AOCI is flat-to-down (~$72→$74) because the company distributes more than it earns. (3) The stock has re-rated, not out-earned — the ~44% twelve-month move took the forward operating P/E from ~8x to ~12–13x, to an all-time-high price at the 96th percentile of its own ten-year valuation range, with no insider open-market buying and mechanical buybacks. GAAP earnings are genuinely noisy (a non-cash funds-withheld embedded derivative swung reported net income by ±$0.4–1.1B), so operating metrics are the honest lens — but even on operating metrics, the price now embeds durable low-teens growth that the company’s own net flows do not yet support. This memo takes no position; the labeled Claude’s Take above does.

2. Business Overview

Principal Financial Group, founded in 1879 and public since 2001, is a diversified retirement, asset-management, and insurance company serving ~82 million customers across 27 markets, with ~19,700 employees. It reports three operating segments plus Corporate.

Retirement & Income Solutions (RIS) — FY2025 pre-tax operating earnings $1,185.6M (44.9% of segment total), operating revenue ~$8.2B. This is the historical heart of Principal: US workplace savings and retirement. Through its Workplace Savings & Retirement Solutions (WSRS) business it recordkeeps >42,000 defined-contribution plans holding ~$625B for ~11.3M eligible participants, spanning 401(k)/403(b), defined-benefit, nonqualified, and — after the May-2024 Ascensus deal — the #1 US employee-stock-ownership-plan (ESOP) franchise. RIS also houses pension risk transfer (PRT), income annuities, RILA/variable annuities (a deliberately small ~$7.4B VA book after the de-risking), guaranteed products/funding agreements, IRAs, and Principal Bank/Trust. Revenue is a blend of fees (asset- and participant-based recordkeeping and management fees) and spread (on general-account guaranteed products, PRT, and funding agreements). Operating margin ~41.5% (Q1-26), at the high end of target.

Principal Asset Management (PAM) — FY2025 pre-tax operating earnings $930.2M (35.2%), operating revenue ~$2.8B. Two sub-parts: Investment Management (Principal Global Investors — global equities, fixed income, and a differentiated real estate / infrastructure / private-credit capability; named PERE’s 2025 “Data Center Firm of the Year”); and Principal International (PI) — pension and asset-management JVs and subsidiaries in Brazil (Brasilprev), Chile (Cuprum), Mexico, China (CCB Principal, 25%-owned), Hong Kong, and Southeast Asia (CIMB-Principal, Malaysia). International pension AUM hit a record ~$160B in Q1-26. This is a pure fee (AUM-based) business.

Benefits & Protection (B&P) — FY2025 pre-tax operating earnings $523.2M (19.8%), operating revenue ~$5.0B. Specialty Benefits — group dental, vision, life, and disability sold to ~103,000 employer groups covering >3.3M employees, where Principal is a leader in the small/mid-business (SMB) niche (#1 group life, #2 group long-term disability, #3 group dental by LIMRA 2024). Plus business-market individual life (universal/variable/indexed/term). Revenue is premium + fee; this segment was the standout in early 2026 (+41% pre-tax in Q1) on favorable mortality and underwriting.

Corporate is a net cost/financing center (FY2025 −$381.2M), holding interest expense, holdco items, and inter-segment tax true-ups.

Segment scorecard (FY2025, pre-tax operating earnings and key drivers):

Two features stand out. First, the mix is stable — RIS ~45% / PAM ~35% / B&P ~20% has held across 2023–25, so no single engine is masking a hollowing of another. Second, the revenue tilt is capital-light: recordkeeping and asset-management fees plus group-benefits premium dominate, with the capital-consumptive spread businesses (PRT, funding agreements, the small annuity book) deliberately contained after the 2021–22 de-risking. RIS still blends fee and spread — management explicitly manages the two “holistically” and has grown spread-based capital-preservation products (stable-value/general-account solutions, +~$400M of flows in Q1-26) alongside fee flows.

Verdict. A coherent, if sprawling, “help the small/mid-market employer and its employees save, invest, and protect” ecosystem, with a favorable capital-light tilt (recordkeeping fees, AM fees, group-benefits premium) and a smaller, deliberately-shrunk capital-intensive spread tail (PRT, funding agreements). Recurring revenue is high; the quality question (below) is whether the pieces reinforce each other into a moat, or simply coexist as a diversified aggregator.

3. Industry Dynamics

Principal competes in four structurally distinct arenas, and the blend is mixed — better than a pure life insurer, worse than a pure high-quality asset manager or a scaled specialty underwriter.

US defined-contribution recordkeeping (RIS core). A consolidating, scale-driven, chronically fee-compressed industry. The top players (Empower, Fidelity, Vanguard, Principal, Voya, T. Rowe, Ascensus) compete on basis-point pricing for a commoditizing recordkeeping service; per-participant economics have fallen for a decade. The redeeming feature is stickiness: plan conversions are painful, sponsor relationships are multi-year, and participant balances (and roll-ins) accumulate. It is an attractive business for a scaled incumbent that can defend share and monetize adjacent advice/asset-management/income, and a brutal one for the subscale. Principal is scaled but not dominant.

Global asset management (PAM Investment Management). The tide is against active management: secular fee compression and the relentless active→passive shift. Principal’s core public-equity/fixed-income franchise sits on the wrong side of that capital cycle (Marathon lens), which is exactly why its net flows are negative. The one defensible pocket is real assets and private markets — real estate, infrastructure, private credit — where fees are higher, capital is stickier, and Principal has genuine, decades-long capability (private-markets AUM +11% YoY, ~$9B commitment pipeline). But private markets are ~15–20% of PAM, not the whole, and the industry is now crowded with capital chasing the same allocation.

Pension risk transfer (PRT). A structural tailwind — corporate DB de-risking has years to run — but a capacity-adding one: Athene, Brighthouse, RGA, MetLife and others are pouring balance sheet in, which compresses the spread on new deals. Principal is disciplined (only ~$3B/70 cases in 2025, explicitly “won’t take sales for the sake of sales”), which protects returns but caps growth.

Group specialty benefits (B&P). A mature, competitive, employment-cyclical business. Loss ratios move with mortality/morbidity trends and pricing discipline; the SMB niche rewards distribution breadth and underwriting data. Principal’s leadership here is real but the industry is not structurally advantaged.

International pension (PI). Attractive long-run demographics (mandatory/quasi-mandatory systems in Latin America and Asia) but regulation-distorted — Chile’s AFP reform directly threatens the 98%-owned Cuprum, and the China JV is minority-controlled. Principal is simplifying, not expanding, here (selling Chile annuities, exiting Hong Kong MPF trustee roles).

Where PFG sits in Marathon’s capital cycle. The capital-return lens is unflattering for the largest engine. In active public-market asset management, capital (fee income, competitor entry, and — most damagingly — passive substitutes) has been flooding out of the high-fee active product for a decade, and Principal’s core equity/fixed-income franchise is a price-taker in that mean-reversion: its persistent net outflows are the capital cycle at work. In private markets, by contrast, capital is entering fast (every allocator wants real assets/private credit), which is a tailwind for Principal’s fundraising today but a warning that forward returns and fees on that capital will compress as the cycle matures. In PRT, capacity is being added aggressively — a classic late-cycle “high returns attract capital” signal that argues for Principal’s demonstrated discipline (walking away from thin deals) rather than volume-chasing. Only SMB group benefits sits in a relatively stable, less capital-cycle-whipsawed niche.

Competitor context. In US DC recordkeeping Principal is a scaled top-tier player but sits behind the mega-scale incumbents (Empower, Fidelity, Vanguard) on total assets; in asset management it is a mid-major (~$748B) dwarfed by BlackRock/Vanguard/Fidelity and out-flowed by passive; in PRT it competes with far larger balance sheets (MetLife, Athene, Prudential, Brighthouse, RGA); in group benefits its LIMRA #1/#2/#3 ranks are its cleanest leadership. The pattern: Principal is a leader in the SMB retirement-and-benefits niche and a follower everywhere the industry is largest.

Verdict: a structurally average-to-slightly-challenged mix. Two engines face secular fee/spread compression (AM and PRT), one is mature/cyclical (benefits), one is regulation-distorted (international). The saving grace is the capital-light revenue tilt and the SMB retirement stickiness — not a structurally beautiful industry.

4. Competitive Position

Named moat mechanism (Greenwald taxonomy): customer captivity / switching costs in DC recordkeeping, plus modest scale economies in recordkeeping operations and SMB specialty-benefits distribution. Verdict: a real but MODEST and LEAKY moat — closer to a sticky diversified aggregator than a durable-advantage compounder.

The bull narrative is the “integrated flywheel”: Principal recordkeeps a plan, captures the recordkeeping fee, steers plan assets into proprietary PAM funds (capturing the management fee too), and cross-sells the employer group benefits — a vertically integrated machine that monetizes the same SMB relationship three times. There is truth here: the SMB retirement-plus-benefits relationship is sticky, conversions are painful, and Principal is a leader in its niche (LIMRA #1/#2/#3 group ranks; #1 ESOP; a top-tier recordkeeper by participants).

But the flywheel is two-thirds hollow, and the evidence is in the filings:

• Only ~30% of WSRS recordkept account values are managed by proprietary PAM; ~66% flow to unaffiliated third-party managers. The “capture the management fee too” leg of the thesis fails on two-thirds of the assets Principal touches. Open-architecture plan design (which sponsors and fiduciaries increasingly demand) structurally caps proprietary capture.
• The AM franchise is in persistent net outflow (−$10.6B in 2025), so the flywheel is spinning against a headwind — assets are leaving PAM faster than the recordkeeping funnel feeds it, with only market appreciation masking the erosion.
• Ratings are strong but not top-tier (A.M. Best A+, Fitch AA, Moody’s A1, S&P A+). Good enough to qualify for PRT’s “safest available annuity” fiduciary bar, but Principal is not the ratings leader that wins the most competitive institutional mandates.

The switching-cost mechanism, weighed honestly. In DC recordkeeping the captivity is genuine but bounded. A plan conversion is a multi-quarter, operationally-risky project (participant data migration, blackout periods, re-enrollment, fiduciary sign-off), so sponsors are sticky and re-bid infrequently; participant balances accrete via payroll deferrals and roll-ins (Principal booked ~$1.7B of roll-ins in Q1-26 alone), and the average deferral and participation rates grind up. That is real captivity — but it protects the recordkeeping fee, which is the most commoditized, lowest-margin part of the value chain, and it does not protect the asset-management fee, because open-architecture fund menus let assets flow to third parties (hence the ~30% proprietary capture). The captivity is therefore worth less than the flywheel narrative implies: Principal is captive-locked into the low-margin leg and competes on the open market for the high-margin leg. The economics confirm this — RIS operating margin is healthy (~41.5%) but its growth is slow and lumpy, and its net cash flow (~$1.8B account value in a strong quarter) is modest against a $625B base.

Where the moat is most real is SMB specialty benefits — distribution breadth, underwriting data across ~180,000 combined employer relationships, and pricing discipline produced a 58.5% loss ratio and +41% pre-tax earnings in Q1-26. That is a genuine, if cyclical, edge. Where it is weakest is core active asset management, which has no durable advantage and is being out-competed by passive.

Does the moat show up in returns? Operating ROE ~15% is respectable, but a meaningful slice of it is financial leverage and the reinsurance-freed capital funding buybacks, not pure franchise economics. Compared to a true wide-moat compounder (an Ameriprise at ~50%+ ROE, or a scaled recordkeeper with dominant share), Principal’s returns are good-not-great and partly manufactured. Verdict: a modest, fee-compression-exposed moat with one genuinely strong leg (SMB benefits) and one structurally leaking leg (active AM).

5. Growth History and Forward Opportunities

History. The reported growth record is respectable on the surface and modest underneath:

• Operating earnings ($): ~$1,603M (2023) → ~$1,641M (2024) → ~$1,866M (2025) — a ~8% CAGR, with 2025’s step-up flattered by a benefits-underwriting/mortality bounce (B&P +41% pre-tax in Q1-26) that is unlikely to repeat at that pace.
• Operating EPS: ~$6.55 → ~$6.97 → ~$8.27 (management cites ~$8.55 excluding significant variances, ~+12–19% YoY) — growing faster than dollar earnings because the share count fell ~11% over the period. The buyback is doing a large share of the per-share work.
• AUM: $683.4B → $747.8B PAM (total company $781.0B) — but the entire increase was market appreciation (+$69.1B in 2025) and FX (+~$20B); organic net cash flow was negative (−$10.6B PAM in 2025; −$1.5B total company in Q1-26). This is the single most important growth fact: the assets under management are growing despite, not because of, the franchise.

The flow decomposition — the crux of the growth debate. Principal’s AUM growth is almost entirely exogenous. Reconstructing the 2025 PAM rollforward: beginning AUM ~$683B → ending ~$748B, a ~$64B increase, built from +~$69B market appreciation, +~$20B FX, −$10.6B net cash outflow, and −~$15B divestitures/exits. In other words, every dollar of AUM growth (and then some) came from markets and currency; the franchise itself shed assets on a net basis. The Q1-26 detail sharpens the picture: record gross sales (+21% YoY, ~$37B) were more than offset by redemptions concentrated in US active equity in the wealth channel (advisory model changes, allocation shifts), leaving total-company net cash flow at −$1.5B even in a “much improved” quarter. The growing pieces are real but small relative to the bleed: private markets +~$3.5B (2025), international +$1.5B (Q1-26), active ETFs +$1.8B (TTM). The bull needs these to out-scale the active-equity/legacy runoff; three years of data say they haven’t yet.

Forward opportunities (and their credibility):

• Private markets / alternatives — the highest-quality growth lever: +$3.5B net inflow in 2025, an ~$9B commitment pipeline (up from ~$6B historically, now diversified beyond real estate), the $3.6B data-center growth fund. Credible and defensible, but not large enough yet to offset the active-equity bleed.
• Specialty benefits — record sales (+24% Q1-26), Beam Benefits acquisition adds ~25,000 SMBs; management targets the upper end of a 5–9% medium-term range. Credible and organic.
• Retirement ecosystem — transfer deposits +35% YoY in Q1-26, roll-ins, DCIO (~$8B TTM), spread-based capital-preservation products (SGAs). Genuine but lumpy (large-case PRT/transfers), and RIS net cash flow is modest (~$1.8B account-value NCF in a strong quarter).
• International — a shrinking footprint by choice (exiting Chile annuities, HK MPF), leaving FX-exposed pension JVs; a diversifier, not a growth driver.

Verdict: LOW-to-MEDIUM-quality growth. The guided 9–12% operating-EPS algorithm rests heavily on buybacks and market beta, with genuine organic share gain concentrated in two pockets (private markets, SMB benefits). The company’s own persistent AM net outflows contradict the “growth compounder” narrative the current multiple embeds.

6. Financial Quality

Five-year financial summary (as reported / reconciled to filings):

The 2022 GAAP EPS of $18.63 is the single loudest reminder that GAAP is unusable here — it reflects one-off gains from the reinsurance/exit transactions, not $4.7B of economic earnings. The clean read is the operating line: ~8% dollar-earnings CAGR, a share count down ~14% over five years, operating EPS crossing $8 in 2025, and a book value that has barely moved. Every per-share improvement has a buyback fingerprint on it.

Earnings quality — read on the operating basis; GAAP is genuinely noisy but the noise is non-economic. GAAP diluted EPS ($2.55 / $6.68 / $5.25 for 2023–25) is distorted primarily by the mark-to-market on the funds-withheld embedded derivative tied to the 2022 reinsurance of exited annuity/ULSG blocks: the change in its fair value was −$1,085.7M (2023), +$447.4M (2024), −$381.1M (2025). This is non-cash and economically offset by the funds-withheld assets, so its exclusion from operating earnings is legitimate. Actuarial assumption reviews are disclosed but not excluded (favorable +$53.0M in 2025, +$68.8M in 2024). Non-GAAP operating earnings (~$1,603M / $1,641M / $1,866M) are the honest run-rate.

Margins & returns. Operating margins are healthy and expanding (RIS ~41.5%, International Pension ~48.5%, Specialty Benefits loss ratio improving to ~58.5% in Q1-26). Non-GAAP operating ROE rose 12.8% → 13.2% → 15.2% (15.7% ex-variances), inside the 14–16% target — a real improvement, though partly leverage- and buyback-assisted.

Cash generation & capital. Operating cash flow ~$4.5B/year (an insurance figure inflated by policyholder flows; the relevant metric is deployable capital). Management targets 75–85% free-capital-flow conversion and hit ~85% of operating earnings in 2025. Holdco liquidity is ~$2.36B (well above the ~$800M target); Principal Life upstreamed ~$1.06B to the parent in 2025 with a ~$1.23B ordinary limit for 2026.

Balance sheet quality is a genuine strength:

• Credit: only 4.9% below-investment-grade fixed maturities (15% internal limit); 95.1% investment grade. Net AFS unrealized loss narrowed to ~$2.45B (from ~$3.77B).
• Commercial mortgage loans: ~$13.8B (602 loans, avg $23.2M; California ~21%; 86% balloon). Problem + potential-problem + restructured loans rose to 1.28% (from 0.77% in 2024) — worth watching but not alarming; loan-loss provisions are declining (−$100.0M in 2024 → −$46.4M in 2025). (Note: the frequently-cited “~35% office” figure applies to the smaller ~$2.4B equity real-estate book, not the CML book; the exact CML office concentration is an open item.)
• Private credit: management is defensive on the industry scare — “vast majority investment grade, minimal direct lending,” 60+ years of underwriting experience, “experience better than long-term expectations.”
• Leverage: total debt ~$3.95B, debt/capitalization ~25% (at/below target).

Investment-portfolio detail (the credit-cycle exposure). The general account is conservatively positioned relative to the life-insurance industry’s recent drift into private credit. Below-investment-grade fixed maturities are just 4.9% of the AFS book (a 15% internal limit), leaving 95.1% investment grade; net AFS unrealized losses have narrowed to ~$2.45B from ~$3.77B as rates stabilized. The watch item is commercial real estate: the ~$13.8B commercial-mortgage-loan book (602 loans, average $23.2M, ~86% balloon-structured, ~21% California) saw problem/potential-problem/restructured loans rise to 1.28% from 0.77% — a genuine uptick, though loan-loss provisioning actually declined year-over-year (−$100.0M → −$46.4M), suggesting management does not yet see systemic deterioration. On private credit specifically, management’s posture is defensive and specific: “the vast majority of our private fixed-income securities are investment grade, with minimal exposure to direct lending,” backed by 60+ years of underwriting and “experience better than our long-term expectations.” The honest read: this is an above-average-quality life-insurer balance sheet, but it carries the sector’s inherent CRE/credit-cycle beta — the +0.34 credit-risk factor loading and the −91% lifetime drawdown are the market’s memory that this is, at bottom, a levered financial.

The one real quality flag: book value is not compounding. Equity ex-AOCI went ~$72.10 → $73.94 per share — essentially flat — because Principal returns >100% of GAAP net income (and ~85% of operating earnings). A capital-return machine that pays out everything does not build book value; per-share growth comes from shrinking the denominator, not growing the numerator.

Verdict: above-average earnings quality once normalized to operating basis, on a genuinely strong and liquid balance sheet — but the growth is financial engineering plus market beta, and book value does not compound.

7. Capital Allocation

Capital allocation is Principal’s defining competence and the engine of the equity story — executed with discipline of size but indifference to valuation.

Return of capital (from the 10-K):

The dividend has risen 12 consecutive quarters (paid-basis ~$2.25 in 2020 → ~$3.07 in 2025), targeting ~40% of operating EPS; the share count fell 273.3M → 217.4M (−20.5%) since 2020. The Feb-2024 $1.5B authorization completed in Dec-2025; a fresh $1.5B authorization (no expiry) followed. This is funded by the statutory capital freed by the de-risking, not purely by earnings — hence the >100%-of-net-income payout.

Why the payout can exceed net income — the de-risking mechanics. The >100%-of-GAAP-NI payout is not financial recklessness; it is the harvest of the 2021–22 de-risking. Reinsuring the in-force fixed-annuity and ULSG blocks to the Talcott/Sixth Street vehicle transferred the reserves (and the capital backing them) off Principal’s statutory balance sheet, releasing a large slug of required capital that has been dividended up to the holding company and recycled into buybacks over several years. That is why cash returned has run ahead of reported earnings while the RBC ratio has stayed strong (~400%) and holdco liquidity has risen to ~$2.36B. The flip side, already noted, is that a company distributing its released capital and ~85% of ongoing operating earnings is not retaining enough to grow book value — so the model is structurally a high-payout, low-reinvestment one. That is fine for a mature financial, but it caps the organic compounding rate and makes the equity story unusually dependent on (a) the buyback price paid and (b) the durability of the fee/underwriting earnings being paid out.

Discipline verdict: disciplined in size, mechanical on price. Buybacks ran ~$0.9–1.05B/year at a near-identical ~$82 average in both 2024 and 2025 — a target-driven, calendar-paced program that bought steadily into a rising market and is buying at all-time highs today. There is no evidence of opportunistic, valuation-sensitive repurchase (no acceleration at the 2023 ~$65 low, no pause at the 2026 ~$112 high). For a company whose per-share growth depends on buybacks, valuation-indifference is a modest but real ding.

M&A scorecard:

Incentive alignment (2026 proxy). Annual bonus keys off non-GAAP operating earnings excluding actuarial-assumption-review impact + customer-driven growth (customer revenue growth; managed net cash flow) + culture (earned 104% of target in 2025). LTI PSUs vest on 3-year average non-GAAP ROE + cumulative EPS (50/50), modified by relative TSR (prior cycle paid 83%). Two governance flags: the bonus metric explicitly backs out recurring assumption-review charges; and the CFO’s spouse is a related-party employee (Director-Accounting, ~$232k). The inclusion of managed net cash flow in the bonus is notable — management is paid to fix the very flow problem the franchise has.

Verdict: a genuinely capable capital allocator that has created shareholder value primarily through de-risking and relentless buybacks — but the machine is valuation-agnostic and now buying at record prices.

8. Changes and Headwinds — Last Two Years

Strengthens the thesis: (1) Clean CEO succession — Deanna Strable (former CFO) became President & CEO in January 2025; Dan Houston moved to Executive Chair and retires at the 2026 annual meeting. Orderly, insider continuity. (2) De-risking now paying off in capital-return firepower and a 15%+ operating ROE. (3) Beam Benefits and the Ascensus ESOP position add SMB-benefits growth optionality. (4) Operating momentum — 13% operating-EPS growth and 16% ROE in Q1-26.

Weakens / watch: (1) BofA downgrade to Underperform (2026-06-24, PT $95) on pure valuation — flagging the forward operating P/E re-rate from ~8.2x to ~10.9x (+33%) and expecting operating-income growth to decelerate to mid-single-digit. (2) PAM net outflows persist — the core franchise problem. (3) Recurring actuarial assumption-review charges (excluded from bonus metrics). (4) Chile AFP pension reform threatens 98%-owned Cuprum; China JV is only 25%-owned. (5) CRE/office and rate-spread exposure in the general account, with problem CMLs ticking up to 1.28%. (6) No insider open-market buying through the entire re-rate.

Verdict: the operational changes strengthen the business; the valuation change (the re-rate itself) is the headwind — the improvements are now priced, and the marginal sell-side voice has turned on valuation.

9. Risk Analysis (Risk Matrix)

The dominant, near-certain risk is valuation, not solvency: the balance sheet is strong and the franchise durable enough that a total loss is remote; the live risk is that a fully-priced stock de-rates as growth decelerates and flows stay negative.

10. Valuation Discussion (Embedded Expectations)

Anchor on operating metrics (GAAP EPS is distorted by the funds-withheld derivative) and on book value ex-AOCI (~$73.94/share). Ignore any enterprise-value multiple: for a life-insurer/asset-manager, EV is meaningless (aggregators report a nonsensical −$8B EV by treating separate-account/investment assets as cash). At $112.23:

Peer comparison (year-end 2025 basis; operating estimates):

The picture is stark: PFG trades at a life-insurer’s balance sheet but an asset-manager’s earnings multiple, at a ~50–75% P/E premium to its closest life-insurance peers (PRU, MET) and roughly in line with Ameriprise — a company with 3x+ the ROE and genuine net inflows. The market is paying PFG’s price for a franchise quality it only partially has.

A sum-of-the-parts lens sharpens the tension. Principal is genuinely two businesses stapled together: a capital-light fee machine (PAM’s ~$930M pre-tax + the fee portion of RIS + the fee portion of B&P) that deserves an asset-manager/benefits multiple (~12–16x earnings), and a capital-consumptive spread/insurance business (PRT, funding agreements, the annuity/life tail) that deserves a life-insurer multiple (~8–10x, ~1.0–1.3x book). The problem for the bull SOTP is that the highest-quality piece — the fee-based asset manager that would carry the premium multiple — is precisely the piece in net outflow, so it does not obviously merit the compounder multiple the blended stock now trades at. A defensible SOTP lands the whole in the ~$90–105 range: put PAM’s fee stream at ~13–15x (discounted for negative organic flows), RIS at ~11–13x on its blend, B&P at ~10–12x on its (cyclically-elevated) underwriting, net of holdco debt — and you do not easily reach $112 without assuming the AM flows inflect. The market is effectively applying the fee-business multiple to the whole company while the fee business shrinks organically.

Embedded expectations. A simple justified-multiple frame: at ~1.52x book ex-AOCI with a ~15% operating ROE and ~40% earnings retention (~9% cost of equity), a Gordon-growth screen implies the market is underwriting a sustainable ~7–8% growth-adjusted return trajectory — i.e., the low-teens EPS-growth algorithm delivered durably. What must be true for the price: PAM net flows must inflect toward positive (or at least stop bleeding), operating-EPS growth must hold in the low double digits (not decelerate to BofA’s mid-single-digit), the B&P underwriting tailwind must not reverse, and the buyback must keep compounding per-share at record prices without denting book value further. What the market may be pricing incorrectly: it is capitalizing a benefits-underwriting bounce and a buyback-driven EPS number as if they were durable organic growth, while the franchise’s own net cash flow is negative.

Scenario sketch (illustrative, not a target):

• Bear (~$75–85): growth decelerates to mid-single-digit (BofA case), flows stay negative, multiple de-rates to ~9–10x operating / ~1.1x book ex-AOCI.
• Base (~$90–100): ~8–10% operating-EPS growth, flows roughly neutral, a ~11–12x operating / ~1.2–1.35x book multiple — a modest de-rate from here.
• Bull (~$120–130+): private-markets/international flows turn PAM net-positive, low-teens EPS growth persists, the quality re-rate sticks at ~13–14x operating.

The current price sits at the bull edge. No price target, no recommendation — this is embedded-expectations analysis only.

11. Variant Perception

Consensus. The sell-side is split and turning cautious after the run: price targets span ~$92 (Barclays UW) to ~$125 (Piper OW), clustered near the price, with several equal-weights ($112–114) and a fresh BofA downgrade to Underperform ($95). The prevailing view is “high-quality, well-managed, de-risked diversified financial with strong capital return — fairly-to-fully valued.”

Strongest bull case. Principal is a de-risked, capital-light-tilted compounder with a 15%+ operating ROE, a fortress balance sheet, a 12-quarter dividend-raise streak, and multiple organic growth levers (private markets, SMB benefits, retirement ecosystem) just beginning to inflect. The AM outflows are concentrated in a dying category (US active equity) that is small and shrinking, while the growing pieces (private markets +$3.5B, ~$9B pipeline; international +$1.5B; ETFs +$1.8B TTM) are turning the corner. As net flows go positive, the market will re-rate a quality franchise toward Ameriprise-like multiples. The de-risking permanently lowered the risk profile, justifying a structurally higher multiple than the old Principal ever earned.

Strongest bear case. The ~44% run is entirely multiple expansion (8x→13x operating) on a business whose core asset-management engine bleeds net flows every year, whose book value doesn’t compound (>100% payout), whose per-share growth is manufactured by valuation-indifferent buybacks at record prices, and whose 2025 earnings step-up leaned on an unrepeatable benefits-underwriting bounce. Insiders haven’t bought a share. The moat is two-thirds leaky (30% proprietary capture). At the 96th percentile of its own history and a premium to peers with higher ROEs and positive flows, PFG is priced for a growth durability its own KPIs contradict — and the marginal analyst (BofA) has already called the deceleration. A credit-cycle turn would expose the +0.34 credit-risk loading.

The 3–5 assumptions that matter most:

1. Do PAM net flows inflect positive? (Bull needs yes; three straight years say no.)
2. Does operating-EPS growth hold low-double-digit or decelerate to mid-single? (BofA says decelerate.)
3. Is the 15% operating ROE durable franchise economics or leverage + buyback + a mortality bounce?
4. Does the multiple hold at ~13x or round-trip toward ~9–10x?
5. Does the credit cycle stay benign for the general-account CRE/private-credit book?

Factor-positioning read (feeds the above). The tape confirms the bear framing more than the bull: despite the +44% price run, PFG loads as a Value (+0.30) + Dividend-Yield (+0.50) + Insurance (+0.41) + Credit-Risk (+0.34) financial with negative Growth (−0.22) and neutral Momentum (−0.08). This is not a market that has decided PFG is a growth compounder — it is a cheap income financial that mean-reverted up. Consensus is offsides if it extrapolates the re-rate into a durable quality premium; the factor model says the re-rate was a value/rate/sector move that has now largely run its course. Evidence that would falsify each side: bull is falsified by a fourth consecutive year of PAM net outflows and mid-single-digit EPS growth; bear is falsified by PAM net cash flow turning durably positive and the ROE holding 15%+ without the mortality tailwind.

12. Fact vs. Interpretation Table

13. Open Questions

1. Exact CML office concentration — the 10-K gives a property-type mix but the precise office % of the $13.8B CML book (vs. the $2.4B equity-RE book’s ~35% office) is not cleanly disclosed. Material for the credit-cycle risk.
2. Consolidated RBC ratio — management cites ~400% on the call, but the 10-K only states subs “exceeded minimum”; the exact consolidated figure is not disclosed.
3. Beam Benefits price — undisclosed, so accretion/multiple is un-judgeable.
4. Sustainable B&P margin — how much of the 2025/Q1-26 underwriting bounce is durable vs. favorable mortality that reverses?
5. PAM flow inflection timing — when (if ever) does the ~$9B commitment pipeline + private-markets/international inflow outweigh the active-equity/legacy bleed to turn total PAM NCF positive?
6. Reinsurance counterparty health — the Talcott/Sixth Street funds-withheld structure’s recapture triggers and counterparty exposure.

14. What Must Be True

Bull case — what must be true, and its falsification test:

• PAM net cash flow inflects toward positive as private markets, international, and ETFs outgrow the active-equity bleed. Falsified if: total PAM net cash flow is negative again in FY2026 (a fourth straight year).
• Operating-EPS growth holds in the low double digits (9–12% algorithm). Falsified if: 2026–27 operating-EPS growth decelerates to mid-single-digit (the BofA case), revealing the 2025 step-up as a one-off underwriting bounce plus buyback.
• The 15% operating ROE is durable franchise economics. Falsified if: ex-buyback, ex-mortality-bounce ROE drifts back toward ~12–13%.

Bear case — what must be true, and its falsification test:

• The stock de-rates from ~13x operating as growth decelerates and flows stay negative. Falsified if: the multiple holds ~13x+ and flows turn positive — i.e., the market’s quality re-rate is validated by fundamentals within 12–18 months.
• The general-account credit book cracks in a cycle turn. Falsified if: CRE/private-credit problem loans stabilize/decline and net investment income holds through a rate/credit wobble.

The single cleanest tell to watch: total-company net cash flow. It is in the bonus scorecard for a reason. If it turns durably positive, the bull thesis has legs; if it stays negative, the price is borrowing from a future that isn’t arriving.

15. Source Appendix

See the Source Appendix (Appendix B) for the full, dated, primary-source list: PFG FY2021–FY2025 Forms 10-K, Q1-2026 10-Q, 2022–2026 DEF 14A proxies, 8-K material-event and earnings filings, the Form 3/4/5 insider corpus, Q4-2025 and Q1-2026 earnings-call transcripts, and public market/valuation/factor data. Every material claim traces to a dated primary source.

APPENDIX A — Standard Diligence Questionnaire

Principal Financial Group, Inc. (NASDAQ: PFG) — supplemental diligence. Report date 2026-07-11. Fact/Interpretation/Assumption labels applied where it matters. Where a question doesn’t map to a diversified insurer/asset-manager, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? (1) Is the persistent PAM net outflow a terminal franchise problem or a mix issue (dying active equity masking growing private markets)? (2) How much of the 15% operating ROE is durable franchise economics vs. leverage + buybacks + a 2025 mortality bounce? (3) Is the “integrated retirement flywheel” real, given only ~30% proprietary asset-management capture on recordkept plans? (4) How exposed is the general account to CRE/office and private credit in a cycle turn? (5) Does the de-risking (reinsurance of exited blocks) justify a structurally higher multiple, and how much counterparty/recapture risk remains? (6) Is the current ~13x operating multiple — a premium to PRU/MET and near Ameriprise — sustainable?

Cyclicality & Earnings Nature

Cyclical high or low? Interpretation: closer to a cyclical/valuation high. 2025 operating EPS (~$8.27, +~12–19%) leaned on a favorable Benefits & Protection underwriting/mortality bounce (Q1-26 B&P +41% pre-tax) that management itself guides back toward mid-range; the multiple is at the 96th percentile of its own history.

Driven by external environment or internal actions? Both — internal (de-risking, buybacks, expense discipline, benefits pricing) plus heavy external dependence (equity/credit markets drive fee AUM; rates drive spread/VII; the 2025 AUM growth was entirely market + FX).

How stable are revenues? Fairly stable and recurring (recordkeeping fees, AM fees, group premium), but AUM-linked fee revenue tracks markets and the AM base is eroding organically.

Outlook for products/services / market size? Growing but competitive: US retirement (large, consolidating, fee-compressed), private markets/alternatives (genuine growth), group benefits (mature, cyclical), international pension (shrinking by choice). Domestic-plus-international, with international being simplified.

Business Quality & Competitive Moat

Industry more or less competitive? More competitive in the two largest arenas — asset management (active→passive, fee compression) and DC recordkeeping (basis-point price war). PRT capacity is flooding in.

How profitable (ROIC/ROE)? Fact: non-GAAP operating ROE ~15.2% (2025); GAAP ROE ~6.6% is distorted and misleading. For a financial, ROIC/ROE — not a manufacturing ROIC — is the right lens; the operating ROE is respectable but partly leverage/buyback-assisted.

How profitable is the industry / barriers to entry? Moderate. Barriers = scale in recordkeeping ops, distribution breadth in SMB benefits, ratings, and switching costs on plans — real but not fortress-like.

Easily understood? Moderately; the three-segment structure is clear, but GAAP earnings require normalization (funds-withheld derivative) and AUM growth must be decomposed (market vs. flows).

Undermined by foreign low-cost labor? No — regulated domestic financial services.

Do brands matter? Modestly — trust, ratings, and the Principal brand matter in SMB retirement/benefits, but pricing and service dominate.

Nature of competition? Price (recordkeeping/AM fees, benefits rates), scale, service, distribution, and investment performance.

Customer switching costs? Real in DC recordkeeping (painful plan conversions, sticky sponsor + participant behavior) and moderate in group benefits (annual re-bid); low in asset management (assets walk, as the flows show).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The value of the recordkeeping/participant relationships and distribution franchise exceeds carried intangibles; conversely, separate-account and funds-withheld structures inflate gross assets.

Off-balance-sheet liabilities? Standard insurance guarantees, funding-agreement/GIC obligations, and the reinsurance funds-withheld/counterparty structure (Talcott/Sixth Street). Nothing unusual disclosed.

How conservative is the accounting? Reasonable; management transparently reconciles GAAP to non-GAAP and discloses (does not fully exclude) actuarial-assumption reviews. Watch that the bonus metric backs out recurring assumption-review charges.

How CapEx-hungry? Low physical capex (~$0.1B/yr); the “capital intensity” is statutory/regulatory capital backing spread liabilities (PRT, funding agreements) — deliberately reduced by the de-risking.

Capital Allocation & Management

How much FCF, and how used? The relevant metric is deployable/free capital, not accounting FCF (which is inflated by policyholder flows). Management targets 75–85% free-capital-flow conversion; ~$1.59B returned in 2025 (~85% of operating earnings) via dividends + buybacks.

Significant acquisitions recently? Ascensus ESOP (2024, small); Beam Benefits (announced 2026-07-07, undisclosed price); earlier Wells Fargo IRT (2019, ~$1.2B). Net M&A is bolt-on, not transformational.

Buying back shares? Yes, aggressively — shares −20.5% since 2020; ~$0.9–1.05B/yr at ~$82 average. Interpretation: disciplined in size, valuation-indifferent (buying at all-time highs).

Issuing shares to insiders? Normal equity comp (SBC ~$110M/yr); no unusual dilution — buybacks more than offset.

Compensation policy / motivations. Bonus = non-GAAP operating earnings (ex-assumption-review) + customer growth (revenue growth; managed net cash flow) + culture; LTI = 3-yr avg non-GAAP ROE + cumulative EPS (50/50) modified by relative TSR. CEO ownership requirement 7× base. Flag: CFO’s spouse is a related-party employee (~$232k).

Valuation & Market Data

ADR, MLP, or K-1? No — US C-corp common stock (NASDAQ), issues a 1099. Not an ADR/MLP/K-1.

Dividend policy? ~$3.08/yr declared (~$0.82/qtr after the Q2-26 raise), ~2.8% yield, targeting ~40% of operating EPS; 12 consecutive quarterly increases.

How profitable? ~15% operating ROE; ~$1.87B non-GAAP operating earnings on ~$781B AUM.

Net income diverging from cash from operations? GAAP net income is noisy (funds-withheld derivative); operating earnings are the clean run-rate. Operating cash flow (~$4.5B) is inflated by policyholder flows and is not a clean earnings proxy.

Risks & Downside

What would cause the stock to decline? A valuation de-rate (most likely — 96th-pctile multiple, all-time-high price, decelerating growth per BofA); continued/worsening PAM net outflows; a credit-cycle/CRE-office impairment; a rate/spread reversal hitting VII; an equity-market drawdown compressing fee AUM; reversal of the 2025 benefits-underwriting bounce.

Risk of catastrophic loss? Low — strong RBC (~400%), 95% investment-grade portfolio, ~$2.4B holdco liquidity, de-risked liability profile.

Chance of total loss? Very low — durable, cash-generative, well-capitalized diversified financial; the live risk is de-rating, not insolvency.

Recent News & Events

Has the business environment changed recently? Incrementally: a broad financials-sector re-rate lifted the multiple; the DOL private-assets-in-retirement guidance is a slow-moving opportunity; the private-credit “scare” prompted management reassurance.

Significant acquisitions? Beam Benefits (announced 2026-07-07).

Change in accounting policies? Beginning Q1-2026, core real-estate depreciation reclassified to realized gains/losses (presentation only; no adjusted-results impact).

Recent changes — new markets, facilities, management? CEO transition (Strable, Jan-2025; Houston retiring at 2026 annual meeting); simplifying international (selling Chile Cuprum annuities, exiting HK MPF trustee roles); $3.6B data-center growth fund; BofA downgrade to Underperform (2026-06-24, PT $95).

APPENDIX B — Source Appendix

Principal Financial Group, Inc. (NASDAQ: PFG). Report date 2026-07-11. Primary sources first. All financial figures reconciled to SEC filings (primary); third-party aggregators (ROIC.ai, AZI, FactorsToday) used for cross-check and market/positioning data and labeled as such. CIK 0001126328.

1. SEC Filings (primary — mirrored locally to output/PFG/sources/)

2. Earnings-Call Transcripts (primary management commentary — via ROIC.ai)

3. Third-Party Quantitative Data (cross-check; not primary)

4. Peer Cross-Reads

• Same-sector US life-insurer/asset-manager peers used for valuation and methodology cross-reference: Prudential Financial (PRU), MetLife (MET), Equitable Holdings (EQH), Voya (VOYA), Ameriprise (AMP) — all public filers with comparable operating-metric disclosure.

5. Key Reconciliations & Analyst Notes

• GAAP vs operating EPS: GAAP diluted $2.55 / $6.68 / $5.25 (FY23–25); non-GAAP operating ~$6.55 / $6.97 / $8.27. Gap driven mainly by the funds-withheld embedded-derivative mark (−$1,085.7M / +$447.4M / −$381.1M) — non-cash, non-economic, correctly excluded.
• AZI TTM EPS $6.99 ≈ GAAP TTM (5.25 − 0.21 + 1.93), not operating; operating TTM ~$8.5.
• Book value: BVPS incl-AOCI ~$54.67; ex-AOCI ~$73.94 (the correct anchor); equity ex-AOCI flat-to-down on >100% payout.
• Valuation multiples computed at $112.23 (close 2026-07-10). Peer multiples at year-end-2025 basis unless noted.

All figures reconciled to SEC filings, which are the primary authority; third-party aggregated data is used for cross-check and market/positioning context only.